Skip to main content

ADVERTISEMENT

hyperlipidemia

Interview
01/03/2020

Lawrence Garcia, MD

 

St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts

Lawrence Garcia, MD   St. Elizabeth...
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses...
01/03/2020
Vascular Disease Management
Introduction: Pressure ulcers are difficult to avoid even with aggressive prevention strategy, and their impact includes many cases with hypertension (HTN) and hyperlipidemia (HLD). A cha...
10/24/2019
Case Series
08/03/2011

Brion M. Winston, MD

Brion M. Winston, MD
We retrospectively assessed the association of plaque type, digital subtraction angiography, patient characteristics, and incidence of periprocedural myocardial infarction, death, and transient ischemic attack/stroke.
We retrospectively assessed the association of plaque type, digital subtraction angiography, patient characteristics, and incidence of periprocedural myocardial infarction, death, and transient ischemic attack/stroke.
We retrospectively assessed the...
08/03/2011
Vascular Disease Management
Original Research
09/05/2008
Multiple large prospective randomized trials have compared the treatment of patients that have arteriosclerotic occlusive disease or diabetes with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors versus placebo.
Multiple large prospective randomized trials have compared the treatment of patients that have arteriosclerotic occlusive disease or diabetes with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors versus placebo.
Multiple large prospective...
09/05/2008
Vascular Disease Management